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Objective: To review the evidence for the effectiveness of telephone-psychotherapy 
on psychological outcomes in people with Multiple Sclerosis (MS). 
Methods: We conducted a systematic search of EMBASE, PsycINFO, 
PsycARTICLES, MEDLINE, CINAHL, Web of Science, and hand-searched relevant 
journals to identify randomised controlled trials (RCTs) that evaluated the 
effectiveness of telephone-psychotherapy on psychological outcomes in people with 
MS (last search completed on 1st October 2015). The methodological quality of each 
included trial was assessed, based on a standardised list of methodological criteria. 
Where available, data were extracted and combined in meta-analysis to compute 
effect size estimates. 
Results: Eleven RCTs and 1104 participants were identified.  Meta-analysis found a 
moderate effect of the intervention on depression (SMD of 0.47 (95% CI of 0.21 to 
0.73)). Meta-analysis also found small to moderate short-term effects of the 
intervention on fatigue, quality of life (QOL), MS-symptoms, physical activity, and 
medication adherence, compared to controls and other interventions. RCT designs 
were heterogeneous. All studies had at least one high or unclear risk of bias. 
Conclusion: Telephone-psychotherapy provides small and moderate benefits in 
depression, fatigue, QOL, MS-symptoms, physical activity and medication 
adherence in the short-term. Few gains were sustained in the long term. Studies of 
better quality are needed.  
 










Impact and Implications Statement 
• There is some evidence that providing telephone-psychotherapy for people 
with MS has small-to-moderate benefits on depression, fatigue, physical 
activity, medication adherence, and MS symptoms in the short-term. 
• Telephone-psychotherapy may be an effective and feasible method for 


















Telephone-psychotherapy in Multiple Sclerosis: A systematic review and meta-
analysis. 
Introduction 
Multiple Sclerosis (MS) is a progressive neurological condition with no cure that affects 
two and half million people worldwide (MS Trust, 2015). The majority of those with MS 
have a relapsing-remitting form, whereby symptoms develop during a relapse, typically 
lasting two to six weeks, before remitting. Eventually, symptoms become permanent 
and the condition becomes worse over time, which is called secondary progressive 
MS. MS can have diverse and unpredictable effects on physical and psychological 
functioning (Wilkinson & das Nair, 2013), so there is a need for accessible and 
effective psychotherapeutic support. Psychological and psychosocial problems 
frequently arise in areas such as physical functioning, fatigue, pain, cognition, and 
problems with the support they receive from people around them (Khan, Turner-
Stokes, Ng, & Kilpatrick, 2007). These types of problems are thought to be highly 
prevalent in the MS population. The lifetime prevalence of depression in MS, for 
instance, is estimated at 50% (NICE, 2003), compared to 17% in a non-clinical 
population (Blazer & Kessler, 1994). Psychosocial distress may arise through various 
interacting pathways, making the precise aetiology of psychological distress difficult to 
discern. 
 
Many people with MS already take multiple medications for their condition and physical 
sequelae, and the pharmacological management of mood problems adds to their 
medical regimen. Psychotherapy, which has the potential to be effective in this 
population (Thomas, Thomas, Hillier, Galvin, & Baker, 2006), may provide an 




alternative treatment of choice for many. However, those with MS may not be able to 
access face-to-face psychological therapies due to fatigue, reduced mobility and other 
condition-related limitations. Furthermore, clinical experience suggests that 
psychological interventions may be perceived as costly and therefore not always 
funded by healthcare providers. Therefore, research into other ways of making such 
care available is warranted.  
 
Telephone-psychotherapy is an intervention that offers the opportunity to deliver 
psychological therapies to people in their own homes who otherwise might find it 
difficult to travel to a healthcare location to receive face-to-face therapy, or where there 
are limited resources to allow therapists to conduct home-visits. Previous systematic 
reviews have demonstrated the potential effectiveness of telephone-based 
interventions across a broad range of physical (Hailey, Roine, Ohinmaa, & Dennett, 
2011) and mental health domains (Leach & Christensen, 2006), including stroke 
(Johansson & Wild, 2011; Paré, Jaana, & Sicotte, 2007) and spinal cord injury 
(Dorstyn, Mathias, & Denson, 2013; Hailey, Roine, Ohinmaa, & Dennett, 2013). 
Telephone-psychotherapy is thought to work in a similar way to face-to-face delivered 
psychotherapy, but may provide lower attrition rates (Mohr, Vella, Hart, Heckman, & 
Simon, 2008). Client satisfaction and acceptance of telephone psychotherapy has also 
found to be high (Bee et al., 2008). While there are studies which have explored the 
usefulness of telephone-psychotherapy, there is no consensus as to whether it can 
provide a similar quality of care compared to face-to-face interventions at a reduced 
cost (Mistry, 2012). 
 




To our knowledge, there is no systematic review that evaluates the clinical 
effectiveness of telephone psychotherapies on psychological outcomes in MS. Results 
from this review will direct future research and practice on the potential applicability of 
this type of intervention with people with MS. 
 
This systematic literature review aims to determine the effectiveness of telephone-
based psychotherapies for people with MS, compared to those receiving no treatment, 
standard care or other control, on psychological and physical outcomes. 
 
Methods 
We searched the following electronic databases (from inception to 1st October 2015) 
to identify potential studies: EMBASE, PsycINFO, PsycARTICLES, MEDLINE, 
CINHAL, and Web of Science. The search strategy was based around the subjects: 
MS, telephone-based psychotherapies, and RCTs. An example of the search 
strategy is presented in Appendix 1. Manual citation tracking of all primary studies, 
forward citation tracking, and scanning references lists from review articles were 
conducted as another search strategy. The WHO International Clinical Trials 
Registry Platform (ICTRP) and www.clinicaltrials.com were searched to identify 
registered trials that met the inclusion criteria but with no data published. If any trials 
appeared to meet the inclusion criteria, the authors were contacted to request their 
data. 
Trials including people with MS in which a telephone-delivered psychological therapy 
was compared to a control, were sought for inclusion in the review. RCTs and the 
pre-crossover component of randomised crossover trials were considered for 




inclusion if they met other criteria. Papers reporting secondary analysis of studies 
were included if they included between-group comparisons of outcomes of interest 
not reported in the original paper. Studies from conference presentations, 
dissertations or other grey literature were excluded. 
We included trials with patients with all sub-types of MS. Trials with mixed diagnosis 
populations where MS data were not separable were excluded. Trials in which there 
was a comparison between a treatment group that received a telephone-based 
psychological therapy and a control group that either received no intervention or 
another type of intervention were included. To be considered a ‘psychological 
therapy’ the interventions should have been described as wholly or partially based 
on established psychological theories, models or principles. Therapy was considered 
to consist of a minimum of four sessions, so as to eliminate evaluations of telephone 
hotlines or crisis counselling services. Studies that delivered therapy via video-
conference (including web/internet) technologies without adjunct teletherapy were 
excluded. Therapies could be delivered by any trained clinician (e.g. doctors, nurses, 
therapists).  
The primary outcome of interest was depression. If there was more than one 
outcome measure measuring this construct, we used the following hierarchy of 
commonly used tests: 
a) Beck Depression Inventory (BDI) (Beck, Steer, & Carbin, 1988). 
b) Hamilton Depression Rating Scale (HDRS) (Hamilton, 1960). 
c) Any other depression outcomes. 




Secondary outcomes were anxiety, fatigue, quality of life (QOL), MS symptoms, 
medication adherence, and level of physical activity.  
All outcomes were either defined as short-term or long-term. Short-term outcomes 
were assessed immediately post-intervention. Long-term outcomes were defined as 
the outcome assessed nearest to 12 months post-randomisation, within a range of 6 
to 18 months. Separate analyses were conducted for each of these time-points 
where possible. Total scores were taken over domain scores (subtest sections) if 
both were available. If subscale scores were reported without total scale scores, then 
first individual effect sizes were calculated for each subscale, then combined using 
the Rosenthal and Rubin (Rosenthal & Rubin, 1986) method for computing accurate 
combination of effect sizes incorporating the estimated inter-correlation between the 
subscales. Self-report scores were taken over clinician-rated scores if both were 
available. 
Included trials were assessed for methodological quality, and rated using the "Risk of 
Bias Table" from the Cochrane Handbook for Systematic Reviews of Interventions, 
guidelines 5.1.0 (Higgins & Green, 2008). Potential sources of bias were judged to 
be low risk, high risk, or unclear risk by one researcher (BP) and checked by another 
researcher (WV). RdN and NM arbitrated if there were any discrepancies. An overall 
evaluation of the risk for all included studies was completed. 
The review was conducted using the Cochrane Review Manager software, RevMan 
5.3 (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). 
Standardised Mean Difference (SMD) was used as a summary statistic. 




Only data that were deemed to be similar or comparable enough to meaningfully 
pool, on the basis of the outcome measures, were entered into the meta-analysis. 
Depending on the heterogeneity of the data, fixed-effect or random-effects models 
were considered. Where continuous data were available, means and standard 
deviations (SD) were entered into RevMan (Copenhagen: The Nordic Cochrane 
Centre, The Cochrane Collaboration, 2014), and the effect estimate (with 95% 
confidence intervals) was calculated using inverse variance method to apply a 
weighting to each analysis and displayed as a SMD. Where data were dichotomous, 
Mantel-Haenszel analysis was completed to produce an Odds Ratio effect estimate, 
with 95% confidence intervals.  
Where medians with upper and lower quartiles were reported, medians were treated 
as means and interquartile ranges were used to estimate the SD, according to the 
formula: SD= interquartile range / 1.35.  
The data were estimated to be of a roughly normal distribution, if, by subtracting the 
lowest value on each scale from the estimated median and dividing this by the 
estimated SD, the value produced was higher than one. The I2 statistic (Higgins & 
Green, 2008) was used to assess heterogeneity in meta-analysis.   
Results  
A description of the included studies can be seen in Table 1. A total of 125 studies 
were identified after removing duplicates. Based on our inclusion criteria, 11 studies, 
comprising 1104 participants were included in the review, with 1032 participants from 
10 studies included in the meta-analysis (Berger, Liang, & Hudmon, 2004; 
Bombardier et al., 2008, 2013; Cosio, Jin, Siddique, & Mohr, 2011; Egner, Phillips, 




Vora, & Wiggers, 2003; Finlayson, Preissner, Cho, & Plow, 2011; Mohr et al., 2000, 
2005; Mohr, Hart, & Vella, 2007; Turner, Sloan, Kivlahan, & Haselkorn, 2014). The 
PRISMA (Liberati et al., 2009) diagram in Figure 1 details the flow of the search 





Overall the risk of bias was mixed across the 11 included studies, detailed in Table 2 




Comparisons were split into two categories: comparisons of telephone-
psychotherapy to waiting lists or no intervention controls and comparisons of 
telephone cognitive-behaviour therapy (T-CBT) to Telephone Support Emotion 
Focused Therapy (T-SEFT).   
Of the included studies, one was not considered for the meta-analysis: The Baron 
study (Baron, Corden, Jin, & Mohr, 2011) was not included because it did not 
present sufficient data on between-group differences. It reported no significant 
difference between the T-CBT and T-SEFT groups on insomnia, measured using the 
three insomnia sub-items of the HDRS (Hamilton, 1960).  




Where applicable, visual inspections of funnel plots revealed symmetrical 
distributions. 
Comparisons of interventions to waiting list or no intervention controls 
Depression 
Three studies (Bombardier et al., 2013; Egner et al., 2003; Mohr et al., 2000) 
included short-term measures of depression using HDRS (Hamilton, 1960), Centre 
for Epidemiologic Studies Depression Scale (CES-D) (Orme, Reis, & Herz, 1986) 
and the BDI (Beck et al., 1988). A moderate effect on depression was found (SMD of 
0.47 (95% CI of 0.21 to 0.73)), as seen in figure 4 below. Statistical heterogeneity 
assessed using I2 was 0%. The Egner study (Egner et al., 2003) included long-term 
measurement of depression using the CES-D (Orme et al., 1986). A small non-
significant treatment effect was found on depression favouring the control group 
(SMD of -0.33, (95% CI of -1.22 to 0.56)).  
[Figure 4] 
Fatigue 
The Finlayson study (Finlayson et al., 2011) reported short-term effect estimates and 
standard errors for three subscales of the Fatigue Impact Scale (FIS) (Fisk, 
Pontefract, Ritvo, Archibald, & Murray, 1994). The three subscales were converted 
into effect sizes and averaged, taking into account the sub-scale intercorrelation of 
0.87 (Fisk, Ritvo, et al., 1994). A moderate composite effect size was found in favour 
of the intervention (SMD of 0.49 (95% CI 0.82 to 0.17)). One of the two Bombardier 
studies (Bombardier et al., 2008) and the Egner study (2003) reported short-term 




continuous data on fatigue using the Modified Fatigue Impact Scale (MFIS) (Fisk, 
Ritvo, et al., 1994) and the Fatigue Severity Scale (FSS) (Krupp, LaRocca, Muir-
Nash, & Steinberg, 1989). A small non-significant effect favouring the control was 
found (SMD of -0.31 (95% CI of -0.63 and 0.02), as seen in figure 5 below. Statistical 
heterogeneity assessed using I2 was 0%. The Egner study (2003) reported on the 
long-term effects on fatigue on the FSS (Krupp et al., 1989), with no effect found 
(SMD of 0.00 (95% CI of -0.95 and 0.95)). 
[Figure 5] 
Quality of life 
Two studies (Bombardier et al., 2008; Egner et al., 2003) reported short-term data on 
QOL using the Short Form 36 measure (SF36) (Jenkinson, Coulter, & Wright, 1993) 
and the Quality of Wellbeing Scale (QWB) (McDowell, 2006). No effect was found 
(SMD of 0.05 (CI 95% of -0.27 to 0.38)), as shown in figure 6 below. Statistical 
heterogeneity assessed using I2 was 0%.  
[Figure 6] 
The Egner study (2003) reported long-term continuous data on QOL, using the QWB 
(McDowell, 2006), finding no effect (SMD of 0.00 (95% CI of -0.95 and 0.95)).  
Medication adherence 
The Berger study (2004) study reported dichotomous data on medication adherence: 
the number of participants who had stopped taking their medication. A significant but 
negligible effect was found (SMD of 0.12 (95% CI of 0.03 and 0.54). The Turner 




study (2014) reported continuous data on medication adherence, asking how often 
participants had missed doses in the last month. A small non-significant effect was 
found in favour of the intervention (SMD of 0.33 (95% CI of -0.6 and 1.27). The same 
study reported long-term effects of medication adherence, finding a large but non-
significant effect in favour of the intervention (SMD of 0.89 (95% CI of -0.09 and 
1.88)).  
Physical health 
Both Bombardier studies (2008; 2013) reported data on the short-term effects on 
physical health, using the Health Promotion Lifestyles Profile (HPLP-II) (Walker, 
Sechrist, & Pender, 1987,) and the 7 day physical activity recall measure (7-Day Par) 
(Sallis et al., 1985). A small effect was found favouring the intervention (SMD 0.44 
(95% CI of 0.17 and 0.71)), as seen in figure 7 below. Statistical heterogeneity 
assessed using I2 was 0%.  
[Figure 7] 
One Bombardier study (2013) included short-term measures of MS symptoms using 
the MS-Related Symptoms Checklist (Gulick, 1989). A moderate effect was found 
favouring the intervention (SMD of 0.51 (95% CI of 0.09 and 0.93)). 
Comparisons of T-CBT to T-SEFT 
One Mohr study (2005) included short-term measures of depression, using the BDI 
(Beck et al., 1988). A small non-significant effect was found favouring T-CBT (SMD 
of 0.33 (95% CI of -0.03 to 0.69)) compared to T-SEFT. The same study included 




long-term measures of depression, using the BDI (Beck et al., 1988). No effect was 
found favouring either intervention (SMD of 0.06 (95% CI of -0.3 to 0.43)).  
One Mohr study (2007) reported on short-term measures of fatigue, using the FIS 
(Fisk, Pontefract, et al., 1994). A small non-significant effect was found favouring T-
CBT over T-SEFT (SMD of 0.18 (95% CI of -0.18 to 0.54)).  
The Cosio study (2011) included short-term measures of QOL, which was a single-
item question about QOL. A moderate effect favouring the T-CBT over T-SEFT was 
found (SMD of 0.60 (95% CI of 0.43 to 0.84)).  
Discussion 
There is some mixed and poor quality evidence that suggest that providing 
telephone-psychotherapy to people with MS has small-to-moderate benefits on 
depression, fatigue, physical activity, medication adherence and MS symptoms in 
the short-term. This finding appears to be roughly comparable to other systematic 
reviews of telephone therapies in chronic and neurological populations (Hailey et al., 
2011; Johansson & Wild, 2011; Leach & Christensen, 2006), which also offer 
tentative evidence for the potential effectiveness of the intervention.  
Where follow-up data were available, initial gains were not sustained in the long-term 
after the termination of telephone-psychotherapy. The results suggest there is some 
mostly poor quality evidence that providing T-CBT over T-SEFT will have small 
benefits on short-term QOL.  
Overall, the majority of trials were of poor quality, with no studies fully adhering to the 
CONSORT guidelines (Moher, Schulz, & Altman, 2001). Mostly of small and 
moderate sample sizes, the majority of RCTs had high or unclear risks of selection 




bias and performance bias. Just over half had a low risk of detection bias.  However, 
attrition, reporting and other biases were relatively low. All studies had at least one 
high or unclear risk of bias.  
Like other systematic reviews, there is risk of potential publication bias. Any RCTs 
without positive results may not have been picked up by the search strategy.  However, 
funnel plots of multiple comparisons were symmetrical, suggesting this may not be the 
case. The results of this study support the notion that many psychological variables in 
MS are correlated, as telephone-psychotherapy produced similar effects across 
different outcomes. Other psychosocial and functional outcomes may respond to 
similarly to telephone-psychotherapy. Due to limited data, sub-analysis based on sub-
type of MS diagnosis, frequency of telephone calls, or theoretical approach of therapy 
were not conducted. Future research, once more primary studies have been 
conducted in this area, may address these areas in hope of exploring what formats of 
therapy are most effective for whom. 
Almost all studies were based on a specific psychological theory or model, 
commonly motivational interviewing or cognitive behaviour therapy, and demonstrate 
a similar small effect on psychological outcomes. However, the intervention in one 
trial (Finlayson et al., 2011) only very briefly alluded to cognitive-behavioural 
principles and it was not explicit. Nevertheless, one could cautiously conclude that 
the specific theoretical modality of the telephone-support offered does not impact 
significantly upon outcome, much like face-to-face psychotherapy (Wampold et al., 
1997). Although little evidence exists, it may be the case that, like face-to-face 
therapy (Norcross, 2002), telephone-psychotherapy relies upon therapeutic alliance 
for outcome change. Evidence for this comes from a study where better therapeutic 




alliance was found to predict better outcomes in telephone-psychotherapy for people 
with MS and depression (Beckner, Vella, Howard, & Mohr, 2007). Therapeutic 
alliance may feasibly be modified by frequency and intensity of telephone calls. 
Overall, the current literature on telephone-psychotherapy for people with MS is 
sparse and methodologically poor, with most trials not adhering to CONSORT 
guidelines (Moher et al., 2001). However, in terms of clinical impact, the literature 
thus far indicates that telephone-psychotherapy interventions can have small-to-
moderate short-term effects on mental and physical well-being. Nevertheless, more 
well-conducted and reported RCTs following published guidance in this area are 
needed. Although not possible in this review due to small sample sizes and lack of 
information of diagnosing criteria, future reviews may also attempt to conduct sub-
group analyses by MS sub-type or level of disability, theoretical approach and 
frequency/intensity of telephone support. Given potential advantages in terms of 
increased accessibility and reduced cost in telephone-based psychotherapy, findings 
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Appendix 1. Example search strategy 
Example of the search strategy employed by the review with the EMBASE database 
 
1. multiple sclerosis.mp 
2. Multiple Sclerosis (subject heading) 
3. 1 or 2 
4. tele$.mp 
5. phone.mp 
6. Telemedicine/ or Telecommunication/ or teleconsultation (subject headings) 
7. 4 or 5 or 6 
8. RCT 
9. randomi*ed 
10. Controlled Clinical Trial (subject heading) 
11. 8 or 9 or 10 
12. 3 and 7 and 11 
 
 
 
